small molecule

SOLODYN

MINOCYCLINE HYDROCHLORIDE

Loss of exclusivityNovember 2031latest FDA-listed patent expiry
CompanyBAUSCH HEALTH US LLC

Drug detail

Brand nameSOLODYN
Active ingredientMINOCYCLINE HYDROCHLORIDE
StrengthEQ 115MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2009
Marketing statusDISCN

Listed patents

PatentExpiresType
9192615November 2031product
7919483March 2027use U-1078

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SOLODYN patent cliff — loss of exclusivity November 2031 | CliffBio